EUVIMEDObjevte EUVIMED
Open access · CC BY-NC-ND 4.0

Mutant p53 regulates reversible subtype plasticity in pancreatic cancer

June-Ha Shin, Hwa-Ryeon Kim, Jae-Seok Roe

Cellular and Molecular Life Sciences · 2025

DOI: 10.1007/s00018-025-05945-w ↗

At a glance

Journal article in Cellular and Molecular Life Sciences, 2025. Written by June-Ha Shin and 2 co-authors. Institution: Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea. Major MEDLINE topics: Pancreatic Neoplasms, Tumor Suppressor Protein p53, Mutation. 57 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Loss-of-function mutations in the TP53 gene are the most frequent genetic events in human malignancies. However, the extent to which missense TP53 mutations confer oncogenic gain-of-function (GOF) properties remains incompletely understood. Using genetically defined pancreatic cancer organoid models, we demonstrated that mutant p53 provides a selective growth advantage under acute environmental stress and drives molecular transition toward a basal-like state. Transcriptomic analyses showed that under stress conditions, organoids expressing mutant p53 adopted a basal-like gene expression program, a characteristic of a poor prognosis subtype of pancreatic cancer. Furthermore, the molecular subtype was reversed to the classical subtype once it returned to normal growth conditions, suggesting that transcriptional plasticity arises from acute changes in the tissue microenvironment. Given these context-dependent oncogenic properties, our findings suggest that targeting mutant p53 may be a promising therapeutic strategy for pancreatic cancer.

Subjects

MeSH terms (MEDLINE)

Pancreatic NeoplasmsTumor Suppressor Protein p53MutationHumansGene Expression Regulation, NeoplasticAnimalsOrganoidsGain of Function MutationCell Proliferation

Author keywords

Gain-of-functionMutant p53OrganoidPancreatic cancerSubtype

Substances

Tumor Suppressor Protein p53TP53 protein, human

Authors and institutions

  • Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea.
  • Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul, 03722, Republic of Korea. jroe@yonsei.ac.kr.

Cite

APA

Shin, J. H., Kim, H. R., & Roe, J. S. (2025). Mutant p53 regulates reversible subtype plasticity in pancreatic cancer. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-025-05945-w

Vancouver

Shin JH, Kim HR, Roe JS. Mutant p53 regulates reversible subtype plasticity in pancreatic cancer. Cellular and Molecular Life Sciences. 2025. doi:10.1007/s00018-025-05945-w

BibTeX
@article{Shin2025,
  author = {Shin, June-Ha and Kim, Hwa-Ryeon and Roe, Jae-Seok},
  title = {Mutant p53 regulates reversible subtype plasticity in pancreatic cancer},
  journal = {Cellular and Molecular Life Sciences},
  year = {2025},
  doi = {10.1007/s00018-025-05945-w}
}
Start for free →